| Description | Delcasertib acetate is a selective δ protein kinase C (δPKC) inhibitor for the study of acute myocardial infarction and pain. |
| In vivo | 在六周大的雄性 Crl:CD(SD) 大鼠中，Delcasertib acetate（1 mg/kg；经股静脉注射）通过与 TAT47-57 的可逆共轭促进了向肝脏、肾脏和心脏等组织的分布[1]。 |
| Synonyms | KAI-9803, KID1-1, CS-9803, BMS-875944, Delcasertib acetate（949100-39-4 free base） |
| molecular weight | 2940.33 |
| Molecular formula | C122H203N45O36S2 |
| Storage | store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Miyaji Y, et al. Distribution of KAI-9803, a novel δ-protein kinase C inhibitor, after intravenous administration to rats. Drug Metab Dispos. 2011 Oct;39(10):1946-53. 2. Bates E, et al. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation. 2008 Feb 19;117(7):886-96. |